Monitor the actual data presented at ASCRS for signals of strong clinical performance or physician adoption trends. Absent new efficacy or safety data, this event is unlikely to move the stock materially.
Price Chart
Executive Summary
Harrow, Inc. announced that three scientific abstracts featuring its ophthalmic products VEVYE® and ILEVRO® have been accepted for presentation at the ASCRS 2026 Annual Meeting. The presentations will highlight real-world data and post-hoc analyses supporting the clinical use of these products in dry eye disease and post-cataract surgery macular edema.
Key Facts
- Three scientific abstracts on VEVYE and ILEVRO accepted for ASCRS 2026 Annual Meeting
- Presentations will cover real-world treatment patterns, steroid-sparing potential, and impact on visual acuity loss
- ASCRS is a major ophthalmology conference, but abstract acceptance is not a regulatory or commercial milestone
- No new clinical data or financial figures disclosed in the release
Financial Impact
Minimal near-term financial impact; potential for modest long-term brand reinforcement
Risk Factors
- Presented data may be preliminary or retrospective with limited clinical weight
- No guarantee of increased product uptake following presentation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3258016 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 8-K | $30.58 $30.35 | ▼ −0.75% | ▼ −1.30% | $28.75 (−5.98%) |
Oct 5, 2026 21d ago | Press Release | $30.58 $30.35 | ▼ −0.75% | ▼ −1.30% | $28.75 (−5.98%) |
Aug 10, 2026 10w ago | 8-K | $39.42 $39.36 | ▼ −0.15% | ▼ −0.40% | $28.75 (−27.07%) |
Aug 10, 2026 10w ago | Press Release | $39.42 $39.36 | ▲ +0.15% | ▲ +0.40% | $28.75 (+27.07%) |
Aug 6, 2026 11w ago | 8-K | $39.92 $40.44 | ▲ +1.30% | ▲ +0.69% | $28.75 (−27.98%) |
Jul 27, 2026 13w ago | Press Release | $37.46 | awaiting T+1 | — | $28.75 (−23.25%) |
Jul 20, 2026 14w ago | Press Release | $44.45 $43.71 | ▼ −1.66% | ▼ −2.50% | $28.75 (−35.32%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.64 $38.93 | ▲ +3.43% | ▲ +1.66% | $28.75 (−23.62%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.65 $37.64 | ▼ −0.03% | ▼ −0.57% | $28.75 (−23.64%) |
Jun 3, 2026 20w ago | 8-K | $33.32 $34.69 | ▲ +4.11% | ▲ +3.71% | $28.75 (−13.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers